Becton, Dickinson and Company (BDX)
develops, manufactures, and sells medical supplies,
devices, laboratory equipment, and diagnostic products
worldwide.
From BD Website
Zack’s Summary
Zack’s is rating this stock as a SELL! Target $252
Pros
BD recently announced two new cloud-based applications
BD has several new technologies in the pipeline some of which have recently been approved print
BD has a well diversified product line
BD is focused on expansion particularly in the overseas market and in the emerging market.
BD has a strong liquidity position.
The company is profitable but it's sales growth is weak at the moment based on cova 19.
BD is a leading player in safety needles especially for diabetics.
Cons
Stock has been beaten down lately.
Covi19 has effective business
Revenues have been down in the last quarter.
Competition has increased.
Call to Action: BDX is a great Medical Stock with room to grow.
Hint: Search for “best Medical stocks to buy” for other thoughts and ideas.
Hint: Search for “Ticker Investor Relations” for other thoughts and ideas.
Hint: Search for “Is Ticker a buy” for other thoughts and ideas.
Do your own diligence and research!!!
No comments:
Post a Comment